481 related articles for article (PubMed ID: 27397577)
1. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
[TBL] [Abstract][Full Text] [Related]
2. Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.
Banerjee G; Jang H; Kim HJ; Kim ST; Kim JS; Lee JH; Im K; Kwon H; Lee JM; Na DL; Seo SW; Werring DJ
J Alzheimers Dis; 2018; 63(4):1485-1497. PubMed ID: 29843234
[TBL] [Abstract][Full Text] [Related]
3. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
[TBL] [Abstract][Full Text] [Related]
4. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
5. The effect of small vessel disease on motor and cognitive function in Parkinson's disease.
Shibata K; Sugiura M; Nishimura Y; Sakura H
Clin Neurol Neurosurg; 2019 Jul; 182():58-62. PubMed ID: 31078957
[TBL] [Abstract][Full Text] [Related]
6. Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study.
Camarda C; Torelli P; Pipia C; Battaglini I; Azzarello D; Rosano R; Ventimiglia GD; Sottile G; Cilluffo G; Camarda R
Curr Alzheimer Res; 2018; 15(11):1013-1026. PubMed ID: 29962342
[TBL] [Abstract][Full Text] [Related]
7. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
[TBL] [Abstract][Full Text] [Related]
8. Subcortical shape analysis of progressive mild cognitive impairment in Parkinson's disease.
Chung SJ; Shin JH; Cho KH; Lee Y; Sohn YH; Seong JK; Lee PH
Mov Disord; 2017 Oct; 32(10):1447-1456. PubMed ID: 28737237
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.
Gasca-Salas C; García-Lorenzo D; Garcia-Garcia D; Clavero P; Obeso JA; Lehericy S; Rodríguez-Oroz MC
Brain Imaging Behav; 2019 Feb; 13(1):180-188. PubMed ID: 28710667
[TBL] [Abstract][Full Text] [Related]
10. Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease.
Lambert C; Sam Narean J; Benjamin P; Zeestraten E; Barrick TR; Markus HS
Neuroimage Clin; 2015; 9():194-205. PubMed ID: 26448913
[TBL] [Abstract][Full Text] [Related]
11. Cerebral Perfusion and the Burden of Small Vessel Disease in Patients Referred to a Memory Clinic.
Onkenhout L; Appelmans N; Kappelle LJ; Koek D; Exalto L; de Bresser J; Biessels GJ;
Cerebrovasc Dis; 2020; 49(5):481-486. PubMed ID: 33075786
[TBL] [Abstract][Full Text] [Related]
12. Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study.
Molad J; Kliper E; Korczyn AD; Ben Assayag E; Ben Bashat D; Shenhar-Tsarfaty S; Aizenstein O; Shopin L; Bornstein NM; Auriel E
J Alzheimers Dis; 2017; 56(4):1293-1299. PubMed ID: 28157096
[TBL] [Abstract][Full Text] [Related]
13. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
Dadar M; Zeighami Y; Yau Y; Fereshtehnejad SM; Maranzano J; Postuma RB; Dagher A; Collins DL
Neuroimage Clin; 2018; 20():892-900. PubMed ID: 30292088
[TBL] [Abstract][Full Text] [Related]
14. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
[TBL] [Abstract][Full Text] [Related]
15. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric Correlates of Small Vessel Disease Progression in Incident Cognitive Decline: Independent and Interactive Effects.
Kan CN; Gyanwali B; Hilal S; Ng KP; Venketasubramanian N; Chen CL; Xu X
J Alzheimers Dis; 2020; 73(3):1053-1062. PubMed ID: 31884482
[TBL] [Abstract][Full Text] [Related]
17. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Garcia-Diaz AI; Vendrell P; Bargallo N; Tolosa E; Junque C
Mov Disord; 2014 Oct; 29(12):1495-503. PubMed ID: 25100674
[TBL] [Abstract][Full Text] [Related]
18. Cortical thinning is associated with disease stages and dementia in Parkinson's disease.
Zarei M; Ibarretxe-Bilbao N; Compta Y; Hough M; Junque C; Bargallo N; Tolosa E; Martí MJ
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):875-81. PubMed ID: 23463873
[TBL] [Abstract][Full Text] [Related]
19. Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up.
Garcia-Diaz AI; Segura B; Baggio HC; Uribe C; Campabadal A; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Parkinsonism Relat Disord; 2018 Jan; 46():62-68. PubMed ID: 29132765
[TBL] [Abstract][Full Text] [Related]
20. Regional cortical thinning, demyelination and iron loss in cerebral small vessel disease.
Li H; Jacob MA; Cai M; Duering M; Chamberland M; Norris DG; Kessels RPC; de Leeuw FE; Marques JP; Tuladhar AM
Brain; 2023 Nov; 146(11):4659-4673. PubMed ID: 37366338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
